Record stringlengths 1 197k |
|---|
<|newrecord|> nctId: NCT06362122 id: PREDICTO-POLYP briefTitle: Anatomo-clinico-biological Profiles in Severe Nasal Polyps overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2026-04-01 date: 2026-10-01 date: 2024-04-12 date: 2024-04-12 name: Poitiers University Hospital class: OTHER briefSummary: Nasal sinus poly... |
Therapeutic management consists of first-line medical treatment for anti-inflammatory purposes. Local corticosteroid therapy, using nasal sprays, is the background treatment. Surgical management is offered to patients in case of failure of medical treatment. Although effective, surgery does not protect patients from re... |
It is therefore essential to determine an anatomo-clinico-biological correlation associating the anatomopathological profile, the clinical characteristics and the cytokine signature in order to best guide the patient's management, including the initiation of biotherapy. Indeed, patients, according to their clinical, bi... |
<|newrecord|> nctId: NCT06362109 id: Once tubefeeding briefTitle: The Impact of Intermittent Nutritional Tube Supplementation in Elderly Patients With Dysphagia overallStatus: NOT_YET_RECRUITING date: 2024-04 date: 2024-12 date: 2024-12 date: 2024-04-12 date: 2024-04-12 name: Zhao Song Ling class: OTHER_GOV briefSummar... |
Can Intermittent Nutritional Tube Supplementation help improve the nutritional status in Elderly Patients With Dysphagia. |
Participants will be divided into two groups randomly. All patients are given routine rehabilitation and the intervention group is given Intermittent Oro-esophageal Tube Feeding once a day. conditions: Dysphagia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREA... |
<|newrecord|> nctId: NCT06362096 id: pyrotinib diarrhra briefTitle: A Multicenter, Prospective Study of Diarrhea Tolerance of Pyrotinib Combined With Trastumab and Taxane in the First-line Treatment of HER2-positive Advanced Breast Cancer overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2025-05 date: 2026-05 date:... |
<|newrecord|> nctId: NCT06362083 id: 34-317 ex 21/22 briefTitle: Urethral Stricture Database overallStatus: RECRUITING date: 2024-01-15 date: 2034-01-15 date: 2034-03-15 date: 2024-04-12 date: 2024-04-12 name: Medical University of Graz class: OTHER briefSummary: Establishment of a clinical urethral stricture database ... |
<|newrecord|> nctId: NCT06362070 id: COMPAR-G briefTitle: Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy overallStatus: RECRUITING date: 2024-01-31 date: 2024-03-30 date: 2025-07-31 date: 2024-04-12 date: 2024-04-12 name: Azienda Ospedaliera Universitaria Integrata Verona class: OTHER b... |
* DaVinci; |
* Hugo; |
* Versius. |
This study is divided into two phases: in the first phase, gastrectomy will be performed using both the new platforms (Hugo and Versius) and the standard platform (Da Vinci), to evaluate the feasibility of the surgical procedure. In the second phase, the three platforms will be compared to evaluate any differences in t... |
The questions it aims to answer are: |
* Are differences (intra-operative, post-operative, oncological, functional, technical, and economic) among the three different platforms observable? |
* Are there any differences between the three platforms related to the learning curve for surgeons? |
Participants will be enrolled, after obtaining informed consent, in one of the following cohorts: |
1. surgery with the daVinci platform; |
2. surgery with the Hugo platform; |
3. surgery with the Versius platform. conditions: Gastric Cancer conditions: Gastrointestinal Cancer conditions: Neoplasms conditions: Gastric Diffuse Adenocarcinoma conditions: Gastric Neoplasm conditions: Stomach Adenocarcinoma studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: PARALLE... |
<|newrecord|> nctId: NCT06362057 id: ADMNF-0020324 briefTitle: Biomechanical Effects of Digitally Constructed Subperiosteal Implants overallStatus: RECRUITING date: 2024-04-04 date: 2024-06-20 date: 2024-07-27 date: 2024-04-12 date: 2024-04-12 name: Menoufia University class: OTHER briefSummary: Subperiosteal implants ... |
<|newrecord|> nctId: NCT06362044 id: P24-120 briefTitle: A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan overallStatus:... |
Study participants will receive oral treatments of Venetoclax±Rituximab for CLL as prescribed by their study doctor in accordance with approved local label. Adult participants prescribed various treatments Venetoclax±Rituximab will be enrolled. Around 89 participants will be enrolled in the study in sites in Japan. |
Participants will receive oral venetoclax tablets ± intravenously (IV) infused rituximab treatments for CLL according to the approved local label. The overall study duration will be 27 months. |
There is expected to be no additional burden for participants in this trial. All study visits will occur during routine clinical practice. conditions: Chronic Lymphocytic Leukemia studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 89 type: ESTIMATED measure: Percentage of Participan... |
<|newrecord|> nctId: NCT06362031 id: H18.Oncology.12-SR1812 briefTitle: A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Acute Myeloid Leukemia (AML) Receiving Venetoclax Through Chart Review overallStatus: WITHDRAWN date: 2023-06-01 date: 2024-04-30 ... |
Data from up to 700 participants will be collected. No participants will be enrolled in this study. |
Participants' charts will be reviewed. No drug will be administered as a part of this study. The duration of the observation period is up to 10 months. |
There is no additional burden for participants in this trial. All visits must be completed prior to data extraction and participants will be followed for up to 10 months. conditions: Acute Myeloid Leukemia studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 0 type: ACTUAL measure: ... |
<|newrecord|> nctId: NCT06362018 id: MHC/CT/23-24/055 id: MHC/CT/23-24/055, Version No.: type: OTHER domain: Mprex Healthcare Pvt. Ltd. briefTitle: Bioavailability of Three Mitopure Formulations overallStatus: NOT_YET_RECRUITING date: 2024-04-09 date: 2024-05-31 date: 2024-06-30 date: 2024-04-12 date: 2024-04-12 name: ... |
Ultimately, this clinical trial aims to contribute valuable insights into the pharmacokinetic behavior of the different Urolithin A formulations, facilitating informed decisions for future developments and applications in the realm of health and wellness. conditions: Healthy Adults studyType: INTERVENTIONAL phases: NA ... |
<|newrecord|> nctId: NCT06362005 id: AUAREC2023011-1 briefTitle: The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus acronym: RCT overallStatus: NOT_YET_RECRUITING date: 2024-07-01 date: 2024-10-01 date: 2025-03-01 date: 2024-04-12 date: 2024-04-23 name: Al-Azhar Universi... |
<|newrecord|> nctId: NCT06361992 id: BC_SERBIA_2022 briefTitle: Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children overallStatus: COMPLETED date: 2022-03-15 date: 2023-09-15 date: 2024-02-13 date: 2024-04-12 date: 2024-04-15 name: Catalysis SL class: INDUSTRY briefSummary: To verify the ... |
<|newrecord|> nctId: NCT06361979 id: A1811 briefTitle: SHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain Metastases overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2025-05 date: 2026-05 date: 2024-04-12 date: 2024-04-12 name: Huihua Xiong class: OTHER briefSummary: This study aimed to ... |
<|newrecord|> nctId: NCT06361966 id: 2021/00638 briefTitle: Evaluating User Satisfaction and Feasibility of a Remote Model for 3d Scanned and Printed Transtibial Prosthetic Sockets overallStatus: COMPLETED date: 2022-01-11 date: 2023-01-09 date: 2023-01-09 date: 2024-04-12 date: 2024-04-12 name: Tan Tock Seng Hospital ... |
The main question\[s\] it aims to answer are: |
1. To determine the repeatability and user satisfaction with transtibial sockets produced using a remote-digital method as compared to conventional manufacturing methods. |
2. To determine if transtibial prosthetic users have greater prosthetic satisfaction scores across the 4 Prosthesis Evaluation Questionnaire (PEQ) subscales of Utility (UT), Appearance (AP), Sounds (SO) and Residual Limb Health (RL) with the 3D printed socket fabricated through the remote-digital method compared to the... |
3. To determine if transtibial prosthetic users experience greater socket comfort with the 3D printed socket compared to the laminate socket. |
Participants will receive a 3D printed socket (trial intervention) and a laminate socket (control intervention) and will use each socket for a period of 4 weeks.The order of socket use will be randomised. At the end of each 4 week period, participants will rate their comfort and satisfaction with the socket. At the end... |
Participants will attend 6 visits across a total duration of 11 weeks during the course of the study. conditions: Amputation conditions: Prosthesis User studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: TREATMENT masking: NONE count: 16 type: ACTUAL name: 3d printe... |
<|newrecord|> nctId: NCT06361953 id: IR.SBMU.MSP.REC. 1401. 161 briefTitle: Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder overallStatus: COMPLETED date: 2022-06-01 date: 2023-07-01 date: 2023-07-01 date: 2024-04-12 date: 2024-04-12 name: Shahid Beheshti University of Medical Sci... |
In addition, a critical and up-to-date comparison of different treatments for GAD is crucial due to their high costs and unsatisfactory outcomes. EEG neurofeedback training has not reached the same level of evidence as more extensively validated non-pharmacological treatments, such as cognitive behavioral therapy.This ... |
<|newrecord|> nctId: NCT06361940 id: IIT-CHAUDHARY-ENDOCRINE2-OPP briefTitle: Molecular Analyses to Identify Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer overallStatus: NOT_YET_RECRUITING date: 2024-08 date: ... |
<|newrecord|> nctId: NCT06361927 id: SSGJ-707-NSCLC-II-01 briefTitle: A Phase II Study of SSGJ-707 Monotherapy in First-line PD-L1 Positive Advanced NSCLC Patients overallStatus: RECRUITING date: 2024-05 date: 2025-06 date: 2025-07 date: 2024-04-12 date: 2024-04-12 name: Sunshine Guojian Pharmaceutical (Shanghai) Co., ... |
<|newrecord|> nctId: NCT06361914 id: 2314393 briefTitle: Digital CBT-I for Patients With Chronic Pain and Insomnia acronym: Back2Sleep overallStatus: RECRUITING date: 2024-04-12 date: 2026-03-01 date: 2026-09-01 date: 2024-04-12 date: 2024-04-18 name: Odense University Hospital class: OTHER name: Aarhus University Hosp... |
The primary aim of this randomized controlled clinical superiority trial is to investigate whether digitally-delivered CBT-I has a greater effect on insomnia and pain than digitally-delivered sleep hygiene education in patients with chronic pain and comorbid insomnia. |
Secondary objectives are to a) explore whether the pain-relieving effect is mediated by a change in physiological markers of sleep quality, b) whether health care cost and use of medications at 12 months are reduced after digital CBT-I, and c) to explore the effectiveness of digital CBT-I compared with sleep hygiene ed... |
1. Physiological sleep metrics (recorded with ear EEG in subsample of 60 patients). |
2. Self-reported sleep quality. |
3. Quality of life. |
4. Physical and mental health. |
5. Thoughts and beliefs about sleep and pain. conditions: Chronic Pain conditions: Insomnia studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 160 type: ESTIMATED name: Digital CBT-... |
<|newrecord|> nctId: NCT06361901 id: 2023GR0452 briefTitle: Comparison of Therapeutic Effect Between Speech Rehabilitation Program and Speech Therapy in Stroke Patients With Aphasia overallStatus: RECRUITING date: 2023-11-17 date: 2024-12 date: 2024-12 date: 2024-04-12 date: 2024-04-12 name: Korea University Guro Hospi... |
Clinical evaluation tools will be performed before and after the treatment for all patients |
* K-Western Aphasia Battery for aphasia assessment tools |
* Cerebral blood flow changes with near-infrared spectroscopy conditions: Stroke conditions: Aphasia conditions: Speech Therapy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 20 type: ESTIMATED name: Z... |
<|newrecord|> nctId: NCT06361888 id: 2023-012-00CH1 briefTitle: A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer overallStatus: NOT_YET_RECRUITING date: 2024-05-31 date: 2027-08-31 date: 2027-08-31 date: 2... |
<|newrecord|> nctId: NCT06361875 id: VAV00045 id: U1111-1295-2852 type: REGISTRY domain: ICTRP briefTitle: A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above overallStatus: RECRUITING date: 2024-04-01 date: 2025-05-22 date: 2025-05-22 date:... |
<|newrecord|> nctId: NCT06361862 id: WARD - Overtreatment briefTitle: Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients? acronym: WARD-OT overallStatus: RECRUITING date: 2024-01-01 date: 2025-03-01 date: 2025-04-01 date: 2024-04-12 date: 2024-04-12 name: Rigsh... |
<|newrecord|> nctId: NCT06361849 id: 55013 briefTitle: TauTona Pneumoperitoneum Assist Device (TPAD) acronym: TPAD overallStatus: ENROLLING_BY_INVITATION date: 2024-01-01 date: 2024-12-31 date: 2025-06-01 date: 2024-04-12 date: 2024-04-24 name: Stanford University class: OTHER name: TauTona Group briefSummary: The purp... |
<|newrecord|> nctId: NCT06361836 id: SBT777101-02 briefTitle: Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa overallStatus: RECRUITING date: 2024-05 date: 2026-06 date: 2026-06 date: 2024-04-12 date: 2024-04-12 name: Sonoma Biotherapeutics, Inc. class: INDUSTRY briefSummary: This study wil... |
<|newrecord|> nctId: NCT06361823 id: IIH-Semaglutide briefTitle: Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2024-12-01 date: 2025-01-01 date: 2024-04-12 date: 2024-04-12 name: Capital Medical Uni... |
<|newrecord|> nctId: NCT06361810 id: IRB00430008 briefTitle: PSMA Therapy and Immunotherapy in Kidney Cancer overallStatus: NOT_YET_RECRUITING date: 2024-07 date: 2030-07 date: 2031-07 date: 2024-04-12 date: 2024-04-12 name: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins class: OTHER name: Merck Sharp & Doh... |
<|newrecord|> nctId: NCT06361797 id: IRB00415412 briefTitle: Varying Bone Marrow-Derived Mesenchymal Stem Cells Concentrations' Impact on Rotator Cuff Repair Outcomes overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2026-05 date: 2027-10 date: 2024-04-12 date: 2024-04-12 name: Johns Hopkins University class: OTHER... |
<|newrecord|> nctId: NCT06361784 id: INT216-23 id: MFAG27480 type: OTHER_GRANT domain: AIRC Foundation for Cancer Research in Italy briefTitle: Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS) acronym: LM overallStatus: RECRUITING... |
<|newrecord|> nctId: NCT06361771 id: 29BRC24.0079 - PRICELESS briefTitle: Evaluation of Invisible Preparation Behaviors of Middle and High School Students in Sports Facilities (PRICELESS) acronym: PRICELESS overallStatus: RECRUITING date: 2024-01-08 date: 2024-12-20 date: 2024-12-20 date: 2024-04-12 date: 2024-04-18 na... |
The CMS (Brest Metropolitan Area Sports Medicine Centre, France) aims at preserving the health of young athletes. Prior to their medical examination, the patients will be asked, all along the year 2024, to fill out a form that question them about their health behaviors in the four areas of the IP. |
Under the direction of the Brest University Hospital, PRICELESS (Invisible Preparation of Middle and High School Students in Sports Institutions) study will try, based on their answers, to estimate the proportion of young athletes who declare adopting the health behaviors recommended in the IP. conditions: Sports Injur... |
<|newrecord|> nctId: NCT06361758 id: B2023-326(2) briefTitle: Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC overallStatus: NOT_YET_RECRUITING date: 2024-05-31 date: 2026-05-31 date: 2027-05-31 date: 2024-04-12 date: 2024-04-16 name: Shanghai Zhongshan Hospital class: OTHER name: Sun Yat-sen... |
<|newrecord|> nctId: NCT06361745 id: PG-005-6 briefTitle: Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases overallStatus: RECRUITING date: 2024-04-02 date: 2024-12-01 date: 2025-03-01 date: 2024-04-12 date: 2024-04-15 name: PersonGen BioTherapeutics (Suzhou) Co., Ltd.... |
To evaluate the safety of UTAA09 injection in the treatment of relapsed/refractory (R/R) autoimmune disease (AID). |
Secondary purpose: |
To evaluate the pharmacokinetic (PK) profile of UTAA09 injection in patients with R/R AID. |
To evaluate the pharmacodynamic (PD) characteristics of UTAA09 injection in patients with R/R AID. |
To evaluate the initial efficacy of UTAA09 injection in the treatment of R/R AID subjects. |
To evaluate the immunogenicity of UTAA09 injection in R/R AID subjects. conditions: Systemic Lupus Erythematosus conditions: Idiopathic Inflammatory Myopathies conditions: Systemic Sclerosis conditions: IgG4 Related Disease conditions: Primary Sjögren Syndrome studyType: INTERVENTIONAL phases: NA allocation: NA interve... |
<|newrecord|> nctId: NCT06361732 id: ILBS-liver Transplant-03 briefTitle: Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function. overallStatus: RECRUITING date: 2022-12-17 date: 2024-10... |
metabolizers have a low C/W-D ratio and require higher Tacrolimus dosing and are thus susceptible to renal and metabolic toxicities, EBV viremia and post transplant lymphoproliferative disorder. Polymorphisms in ABCB1 (c.3435C\>T) are also known to influence tacrolimus dosage in the first week of transplant (C/D ratio ... |
<|newrecord|> nctId: NCT06361719 id: 2312INF briefTitle: Efficacy of Two HMOs in Chinese Infants overallStatus: NOT_YET_RECRUITING date: 2024-05-31 date: 2026-11 date: 2027-06 date: 2024-04-12 date: 2024-04-12 name: Société des Produits Nestlé (SPN) class: INDUSTRY briefSummary: This is a randomized, controlled, double... |
<|newrecord|> nctId: NCT06361706 id: 24/047-P briefTitle: VR-Enhanced Psychoeducation for Chronic Pain: A Primary Care Pilot Study acronym: REDOCVR overallStatus: RECRUITING date: 2023-12-04 date: 2025-12 date: 2025-12 date: 2024-04-12 date: 2024-04-26 name: Badalona Serveis Assistencials class: OTHER name: Department ... |
Key objectives and related measured variables include: |
Usability and Feasibility: Evaluated through the System Usability Scale (SUS) responses from both participants and healthcare professionals, assessing the ease of use and integration of VR into the psychoeducational program. |
Participant Engagement and Program Adherence: Determined by participants\' satisfaction with the VR system, using Likert scale questionnaires, and tracked through session attendance and program completion rates. |
Impact on Chronic Pain Management and Emotional Well-being: Assessed through changes in the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), and the Hospital Anxiety and Depression Scale (HADS) collected at baseline, post-intervention, and 4-8 weeks follow-up Self-management of Chronic Pain: Monitored through the Ce... |
Healthcare Professionals\' Perceptions: Investigated using SUS scores and qualitative feedback on the applicability and benefits of VR in clinical practice for chronic pain management. |
Participants will complete eight 90-minute sessions, engaging with VR to supplement the program\'s content. This approach aims to provide immersive experiences that deepen the understanding and management of chronic pain. Participant feedback on the VR experience, alongside observed changes in pain management and o... |
By targeting individuals suffering from chronic pain, this research aims to offer healthcare professionals an innovative tool for enhancing pain management strategies. Integrating VR into psychoeducational content, the study seeks to promote more engaging and effective learning experiences, potentially leading to impro... |
<|newrecord|> nctId: NCT06361693 id: APHP240147 id: 2024-A00143-44 type: OTHER domain: France : Ministry of Health briefTitle: Descriptive Observational Study of Patient-performed Pre-oxygenation acronym: ApréOx overallStatus: NOT_YET_RECRUITING date: 2024-05 date: 2024-11 date: 2024-12 date: 2024-04-12 date: 2024-04-1... |
This is the concept of "self-preoxygenation". conditions: Anesthesia conditions: Anxiety conditions: ASA Physical Status I conditions: ASA Physical Status II studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 110 type: ESTIMATED name: Auto-preoxygenation name: APAIS scale name: Visu... |
<|newrecord|> nctId: NCT06361680 id: Coenzyme Q10 on diabetic child briefTitle: Effect of Coenzyme Q10 on Diabetic Children overallStatus: NOT_YET_RECRUITING date: 2024-10-30 date: 2025-10-30 date: 2025-11-30 date: 2024-04-12 date: 2024-04-12 name: Assiut University class: OTHER briefSummary: Determine the effect of Co... |
<|newrecord|> nctId: NCT06361667 id: 1/02.02.2024 briefTitle: Culture and Well-being: Art as Prescription Therapy ("Art on Prescription") acronym: AoP overallStatus: RECRUITING date: 2024-03-20 date: 2024-12-15 date: 2025-01-15 date: 2024-04-12 date: 2024-04-12 name: KAVADIA ELENI class: OTHER briefSummary: Cluster ran... |
y \~ b0 + b1xtreatment_group + b2xtime + b3xtreatment_groupxtime + covariates (1) |
Where, y is each outcome, b1-b3 are the regression coefficients and covariates denotes covariates at randomisation (DETERMINE) |
The inference of interest for the model concerns b3, the interaction term, as we posit that there will be a difference in slopes between the treatment groups. |
The inference is going to happen via an estimation of the t-statistic, defined as follows" |
t = b3/SE (2) |
Where SE is the standard error for coefficient b3 |
t \> 1.96 (3) |
And 1.96 is the critical value for statistical significance at alpha = 0.05. primaryPurpose: TREATMENT masking: NONE count: 384 type: ESTIMATED name: Arts measure: The Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) measure: Generalised Anxiety Disorder Assessment (GAD-7) measure: The Patient Health Questionnaire-9 (... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.